Let’s build the future of medicine - together.
Join Enveda as a Program Strategy & Operations Director and help us transform natural compounds into life-changing medicines. We’re a team driven by curiosity and innovation - are you ready to make a difference?
Remote | Full-Time | $215,000 - $230,000
What Makes Us Enveda
Life is smart, and we can learn from it. We’re reinventing drug discovery by harnessing nature’s intelligence. Our platform identifies new medicines four times faster than the industry standard because patients can’t wait. What sets Enveda apart isn’t just what we do - it’s how we do it. Our culture is built on creativity, collaboration, and deep respect for each other. We believe “People Create All Value”, and our success is driven by the extraordinary team turning our mission into reality every day.
Our Momentum
Unicorn status: Achieved following a $150 million Series D funding round in 2025
Discovery and innovation: Advanced our first drug candidate to Phase 1 trials in 2024
Award-winning culture:
--Newsweek: Top 100 Global #MostLovedWorkplaces (2025)
--Forbes: America’s Best Startup Employers (2024 & 2025)
--Newsweek: America’s Greatest Startup Workplaces (2025)
--LinkedIn: Top Startups to Watch (2024)
These milestones reflect the impact of our team and we’re just getting started, but they’re only possible because of the diverse talent, perspectives, and relentless drive of our team, and people like you.
Your Role in Our Mission
At Enveda, every role drives impact, and we’re redefining what it means to be a Program Manager. Our Program Strategy & Operations (S&O) leaders are not simply trackers of timelines, they are strategic and operational copilots to the Asset Entrepreneurs who drive each of our therapeutic programs.
You will be the connective tissue across a single-threaded asset team, transforming rich, cross-functional information into sharper strategy and faster high-quality execution. Your work will directly determine how quickly we bring our first-in-class natural-product-derived medicines to the patients who need them most.